Skip to content
DraconiticResearch
Search Sources API
190,860 studies31 sourcesUpdated 12 min ago
Peer-reviewedCC BYJournal for ImmunoTherapy of Cancer

849 A M2-like tumor-associated macrophage-targeted TLR7/8 agonist, UI-102, induces unique and durable antitumor immunity

  • Ayaka Matsumoto1
  • Tadashi Inoue2
  • Nami Mizoguchi2
  • Junki Tashiro2
  • Takatoshi Soga3
  • Naozumi Harada2
  • Mina Tsukamoto1
  • Yasuhiro Nagai1
  1. 1United Immunity Co., Ltd., Kobe, Hyogo, Japan
  2. 2United Immunity, Co., Ltd., Kobe, Hyogo, Japan
  3. 3United Immunity Co. Ltd, Kobe, Hyogo, Japan
Open at sourcePDFDOICite

Related

  1. A Nitric Oxide–Based STING Agonist Nanoadjuvant With ICD‐Derived Membrane Antigens Unleashes Robust Antitumor Immunity
    Shuyu Xu, Yang Song, Tianjiao Zhang +5
    Exploration (Beijing, China)Peer-reviewedCC BYFull textImmunologyEurope PMCPMC
  2. 733 Macrophage-dendritic cell-T-cell tetrads orchestrate antitumor immunity and response to checkpoint blockade
    Xi Chen, Padmanee Sharma, James P Allison +15
    Journal for ImmunoTherapy of CancerPeer-reviewedCC BYFull textImmunologyDOAJ
  3. MHCII+ cancer-associated fibroblasts promote antitumor immunity in pancreatic cancer
    J. Hung, S. Silveria-Davies, J. Vickery +6
    bioRxivPreprintAll rights reservedFull textImmunologybioRxiv
  4. Damage-Associated Molecular Patterns and Trained Immunity of Monocyte-Macrophage Populations in Osteoarthritis: Potential Molecular Links and Therapeutic Opportunities.
    Jian Zhang, Bingbing Chen, Yundong Xu +5
    CellsPeer-reviewedCC BYFull textCell biologyEurope PMC
  5. Deoxysphingolipids activate cGAS-STING and enhance antitumor immunity
    Suchandrima Saha, Fabiola N. Velazquez, Fatemeh Dehpanah +5
    Cell ReportsPeer-reviewedCC BY 4.0ImmunologyCrossref

Cite

BibTeXRIS
BibTeX
@article{matsumoto2026m2like,
  title = {{849 A M2-like tumor-associated macrophage-targeted TLR7/8 agonist, UI-102, induces unique and durable antitumor immunity}},
  author = {Ayaka Matsumoto and Tadashi Inoue and Nami Mizoguchi and Junki Tashiro and Takatoshi Soga and Naozumi Harada and Mina Tsukamoto and Yasuhiro Nagai},
  journal = {Journal for ImmunoTherapy of Cancer},
  year = {2026},
  month = nov,
  doi = {10.1136/jitc-2026-sitc2026.0849},
  url = {https://doi.org/10.1136/jitc-2026-sitc2026.0849},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - 849 A M2-like tumor-associated macrophage-targeted TLR7/8 agonist, UI-102, induces unique and durable antitumor immunity
AU  - Ayaka Matsumoto
AU  - Tadashi Inoue
AU  - Nami Mizoguchi
AU  - Junki Tashiro
AU  - Takatoshi Soga
AU  - Naozumi Harada
AU  - Mina Tsukamoto
AU  - Yasuhiro Nagai
PY  - 2026
DA  - 2026/11/06
JO  - Journal for ImmunoTherapy of Cancer
DO  - 10.1136/jitc-2026-sitc2026.0849
UR  - https://doi.org/10.1136/jitc-2026-sitc2026.0849
SN  - 2051-1426
ER  -